UMRS 1166 / IHU ICAN monthly scientific seminars
Sharing knowledge with our scientific and medical community is an integral part of the ICAN IHU’s mission. A better understanding of cardiometabolic diseases and the progress made in their treatment make it essential to disseminate this new expertise.
With this in mind, the ICAN IHU and UMRS 1166 have set up monthly seminars to communicate and exchange information with our community on the latest scientific and medical developments at the IHU.
Below are the subjects and dates of these conferences, which are open to all and can be attended online or in person.
2025
6 May 2025 at 12.30 pm | Scientific integrity: from definition to the consequences of breaches
Claude FOREST – Honorary Director of Research at Inserm, Université Paris Cité
18 February 2025 at 12.30pm | Lipid metabolism in thermogenic adipose tissues
Jörg HEEREN – Professor of Biochemistry and Deputy Director of the Institute of Biochemistry and Cell and Molecular Biology at the Hamburg-Eppendorf University Medical Centre in Germany
2024
1 October 2024 at 12.30 pm | Deciphering the complexity of mitochondria populations in cardiomyocytes: insights into cardiac cellular bioenergetics and function
Céline GALES – Research Director at the Institute of Metabolic and Cardiovascular Diseases
11 June 2024 | Markers of adipose dysfunction in humans: associated risk and response to weight loss interventions
André TCHERNOF – Professor at the University of Laval (Quebec, Canada), Institute of Nutrition
2 April 2024 | PLIN2-positive lipid-activated mononuclear phagocytes: role in vascular remodelling in retinopathies
Xavier GUILLONNEAU – Head of the “Retinopathy and inflammation” research group at the Vision Institute
6 January 2024 | Can hereditary heart disease be recapitulated in the laboratory?
Albano MELI – Montpellier Biocampus Organoid Platform
2023
5 September 2023 | Adipocyte extracellular vesicles: small but strong | Soazig LE LAY – Institut du Thorax
28 June 2023 | Importance of mitochondrial inner membrane integrity in cardiac homeostasis | Erminia DONNARUMMA – Postdoctoral Research Associate – Institut Pasteur
30 May 2023 | Progress and limits of in-vitro hepatic sinusoid design on chip: towards the construction of biomimetic multicellular culture systems | Mathieu HAUTEFEUILLE – Researcher – Developmental Biology Laboratory
Institut de Biologie Paris-Seine Sorbonne Université
28 April 2023 | Role of Iron in Cardiovascular Diseases | Professor Hossein ARDEHALI – MD, PhD – Director of the Feinberg Cardiovascular and Renal Research Institute, Center for Molecular Cardiology, Northwestern University, Chicago, USA
20 April 2023 | Lp(a) and aortic stenosis | Franck BOCCARA – Pr. cardiology and vascular diseases – Umrs 938-Centre de recherche Saint-Antoine
21 March 2023 | Regulation of the cardiac sodium channel Nav1.5 by 14-3-3 | Isabelle DESCHENES – PhD Physiology and Cell Biology – Ohio State University
february 13, 2023 | Atrial fibrillation and pulmonary veins | Lisa GOTTLIEB – Medical Doctor, PhD, Postdoctoral Researcher – Department of Biomedical Sciences University of Copenhagen
31 January 2023 | Characterisation of RNA splicing factors involved in the metabolic regulation of the liver | Santiago VERNIA – Head of the Metabolism and Gene Regulation Group – MRC London Institute of Medical Sciences Imperial College London
2022
24 November 2022 | Exploring the role of classical and non-classical biomarkers in the context of atherosclerotic burden | Chiara MACCHI – Research Fellow – Department of Pharmacology and Molecular Biology – University of Milan
21 October 2022 | Arrhythmogenic right ventricular cardiomyopathies: from animal models to innovative approaches | Jérôme MONTNACH – CNRS Research Fellow – Institut du Thorax – University of Nantes
28 September 2022 | Extra-hepatic actions of PCSK9 & Identification of a gain-of-function variant of LIPC | Cédric LEMAY – Research Director – Institut du Thorax – Equipe 4 Maladies cardiométaboliques – Université de Nantes
20 May 2022 | Resolution of spatial heterogeneity using Nanostring’s high precision profiling and single cell platforms | Jean-Baptiste PENIGAULT – PhD – NanoString
21 April 2022 | Seripin deficiency as a model of adipocyte dysfunction | Xavier PRIEUR – Institut du thorax, Team 4 Cardiometabolic diseases – University of Nantes
31 March 2022 | Genetics and single-cell sequencing to identify new therapeutic targets for cardiovascular disease | Patrick T. ELLINOR – Member of the Broad Institute, Harvard – Director of the Cardiac Arrhythmia Service, Massachusetts General Hospital – Professor of Medicine, Harvard School of Medicine
17 February 2022 | Ultrafast ultrasound and its applications | Mathieu PERNOT – Physics for Medicine Laboratory – ESPCI Paris – Hôpital de la Pitié-Salpêtrière
21 January 2022 | Liver on a chip and 3D models | Cécile LEGALLAIS – Director of the Biomechanics and Bioengineering Laboratory – Compiègne University of Technology
2021
30 November 2021 | Endogenous mobilisation of adipose stromal cells: another means of communication for adipose tissue? | Coralie SENGENES – Head of the Stromagics team – Restore Institute – Toulouse
5 October 2021 | Artificial intelligence and personalised cardiac modelling: learning by heart | Maxime SERMESANT – Computational Cardiology Group Leader – INRIA – Université de Côte d’Azur
14 September 2021 | OCT4-mediated inflammation induces cellular reprogramming at the origin of heart valve development and aortic valve calcification | Michel PUCEAT – Physiopathology of Cardiac Development Team Leader – Institut Marseille Medical Genetics
14 June 2021 | Inherited cardiac disorders affecting young people; Beyond monogenic inheritance | Connie BEZZINA – Department of Clinical and Experimental Cardiology – University of Amsterdam
18 May 2021 | The role of tryptophan metabolism in cardiometabolic diseases | Soraya TALEB – PARCC
6 April 2021 | Immuno-inflammation and myocardial infarction | Jean-Sébastien SILVESTRE – PARCC – Director of the Regenerative Therapies of Cardiac and Vascular Pathologies team
